Sarah A
In her job, Sarah teaches and conducts health research. She has been involving patients and members of the public for about two and a half years.
Sarah is an academic research fellow. Ethnic background: White British.
More about me...
Sarah’s background is in psychology. In her current role as a research fellow, she’s been working on trials and interviewing patients. She began involving people in her research when she was applying for her fellowship, explaining that for her at this stage it was a strategic move. A colleague put her in touch with a patient who had an idea for some research. They submitted a funding application together, which was successful. Having done this, Sarah was invited to speak at training events and has since become involved in delivering training about involvement.
The reasons Sarah continued to involve people in her research aren’t the same as why she started doing it. She described herself as more interested in and committed to it, and said she had lots of questions about it that should be answered. What is involvement? How does it improve research? How can it be made consistent and standardised?
Whilst Sarah said researchers are obliged to do it because research is funded using taxpayers’ money, she recognised there were factors that made this difficult, especially current attitudes to involvement. She suggested that funders don’t adequately resource involvement, so it doesn’t stand the best chance of making a difference to research. Equally, responsibility for it is usually given to the most junior, and least experienced, member of the research team, and Sarah would like to see more senior academic staff engaging with it. She also said that universities need to be better equipped to deal with patients and members of the public, particularly when it comes to the time it usually takes for expenses to be reimbursed.
As Sarah sees the research she conducts as a collaborative effort with patients and members of the public, she thinks all members of the project team should have an equal say in it. Whilst she said she believes in the value of involvement and that it can make a difference, she recognised there are potential problems with it and is frustrated that these are often not reported; only the benefits of involvement tend to be written about, which will not convince sceptical researchers.
Sarah believes most researchers are motivated to make a difference for patients and would encourage patients not to collude with those who may be see involvement as a tokenistic exercise. She thinks more research is needed to build up the evidence base for involvement and that researchers shouldn’t be afraid to only report the positive impacts they’ve found. She would like to see more accountability and transparency in the reporting of involvement.
Involvement is primarily about social democracy and transparency for Sarah A.
Involvement is primarily about social democracy and transparency for Sarah A.
So a basic one is we're tax payer funded. So we are a public body doing things on behalf of the public; using public money. And so I think in a, sort of, a social democratic sense, the public should have some access to that, some say in how that’s done. That is probably the primary one for me and I think as well we, I always think, you know, when you're writing your grant applications or something and you do your bit about how incredibly important this topic is to patients and how, if you do this project, patients will benefit and it will make patients’ lives better and patients’ are going to love this so much. And I think well, if you can't, then speak to some patients and explain to them the reason it's important and have them at least agree with that or, you know, offer their opinion, does that mean you're lying in that grant application? I suppose the alternative view is that you know better than those patients do - what they want. And I think possibly some researchers do think that.
But for me, then it would come back again to kind of transparency and things. I think the obligation is to at least try to communicate these things to patients. They give them the opportunity to become involved. As I say, it's their money, it's their healthcare and if we're going to say that we do research for patient benefit I think a patient should be able to tell you what that benefit is, or agree with you that it's beneficial, I think. So I suppose that’s what I think.
The assumption that researchers are ‘robotic, unfeeling people’ unless they have patient involvement can feel a bit insulting.
The assumption that researchers are ‘robotic, unfeeling people’ unless they have patient involvement can feel a bit insulting.
Sarah A feels ‘passionate’ about involvement, but thinks some of her colleagues only view it as something fashionable that’s useful for her CV.
Sarah A feels ‘passionate’ about involvement, but thinks some of her colleagues only view it as something fashionable that’s useful for her CV.
Getting people involved is one thing, but finding ways – and funding - to keep them engaged can be a challenge.
Getting people involved is one thing, but finding ways – and funding - to keep them engaged can be a challenge.
But it is early days in doing that and I think, personally, I think being able to offer the support at the start is important because I think on other projects specific groups where I set up sort of PPI meetings or things, it has been quite successful in sort of reaching. So in one city we were trying specifically to reach out to black and minority ethnic groups and we, you know, we managed to do that quite successfully. I think we got sort of five members who came in who were from different, specific groups. But I wonder if then, the fact that we weren’t able to offer them a clear path in and so to say, "OK now if you want to stick with this, which we'd love you to do, you know, this is what we can offer you; this is how to think about whether you want training." We talk a lot about the idea of like a buddy system – getting people buddied up with current members so they’ve got someone to talk to. You know, for me, I think that’s where the gaps in, I think we'd get people who are interested and who bring, you know, these different perspectives that we do need. But then we haven’t got a way of holding onto them.
And I think that is partly a problem with, you know, funding and things because if you're funded for specific projects; so you'll have your money to do your three steering group meetings with this group. There isn’t a pot of money there that says, "And this is for the coffee and the chats later on, to talk to them about whether they want to continue." I mean [involvement group name] itself, one of the big struggles still is funding…
…For [involvement group name], you know, it's, there isn’t a pot of funding for sustainability for that group, despite its success. You know, it's still essentially having to, on a six monthly basis it seems, find a pot of money from different places and as I say, I think there is an obligation then from funders. I think, you know, if someone like the NIHR is going to say, "We want you to have PPI input at all stages before you get grants after the grants have finished," then there needs to be money there for it.
A carer inspired Sarah A’s whole project, made recruitment easier, and improved dissemination. But she feels there isn’t enough academic career recognition of good involvement work.
A carer inspired Sarah A’s whole project, made recruitment easier, and improved dissemination. But she feels there isn’t enough academic career recognition of good involvement work.
Yeah. See in this, I'd still say it depends what you mean by better and – let me think. So I would say, I mean pragmatically speaking, that project would not have existed without her – we weren’t going to do that study. So in the sense that there is a potentially neglected area and my experience so far has been that people think it is a really neglected area. People you know are really glad that research is being done under this topic. That’s better because that wouldn’t have been done unless she had been there to instigate that work. I think pragmatically from my point of view it made my, you know, that start of the project thing where you're desperately trying to get people on-board and you're contacting loads of organisations and saying, "Please help me recruit participants," and that kind of thing. When I could say, "This is because my collaborator on the project, she was a carer herself, and she really cares about this issue," I think that opened doors much more easily so I think that was a practical kind of benefit. I think in terms of the research itself, because in some ways we did; so it was a qualitative study – we did interviews, we did analysis of the interviews –and in some ways I think that went, as it would have anyway.
What I want to know is if her; I think a lot of projects get to that stage and then there's kind of that lull and things can get left, and in some ways I think it is her drive and her passion to see this go somewhere that means that I'm still involved in it for example, and that we're still taking this forward; and maybe that, again it depends what you mean by better – so in that sense I think you know I wrote my paper as perhaps I would have wrote the paper otherwise. You know it has stuff about sociological theory; you do some grounded theory stuff, you write it up, put it in a journal – whether that’s better because she was on-board I don’t know. But now I think this focus on, she just says, she's like, "Oh great it's published, so what does that mean? How is this going to help carers; what can I go and tell these people I've spoken to the project about?" and that I think is good and that I think having that voice in your ear to go, "So seriously what are you going to do with this now?" I think that makes it better but it's weird, I would say I'm glad about that because I think, I think that makes me focus on what's going to happen more.
I would say at the same time it's not always easy and it can be a struggle in the sense that, you know, there's half a dozen things I'm meant to be working on and to then feel like, 'But I should work on that because I now have an obligation to her because we've gone into this together and we started it running and I should stick with that,' and I feel that very strongly but I don’t think there's support for that a lot of the time you know because I think it would be, I think so the higher up it becomes like any other project it's like, well you know, is it going to go on your CV in this way; is it going to definitely lead to this; does it fit with the overarching themes of the faculty that we're meant to be doing to please the Dean or something and, so for me I feel, I feel like that should be one of the things I'm evaluated on to be honest. I feel it should be something that you say, "Well I got into a partnership with this person and I'm sustaining it and we're going to carry on with that."
You know it wasn’t a hit and run of kind of take your idea because it helps me get a grant, I've got a paper, see you, bye. I think there should be more encouragement sort of for people to do that because that would then be kind of this thing, genuine involvement and genuine collaboration and I think that’s only fair really to people who, who have, you know put their heart and soul into kind of doing some research with us. Sorry so to come back to whether that makes me then whether I think that made it a better project or. That made it different to other projects I'm on and I think, I think I feel more confident that this is a project that matters and that it's a valuable thing for us researchers to be throwing our time at. So that feels better for me and whether that’s objectively measureable and better I don’t know so yeah [laughs].
There isn’t enough evidence for involvement, and mostly its ‘rose-tinted case studies’. We need better reporting of involvement, but also more clarity on what ‘impact’ means.
There isn’t enough evidence for involvement, and mostly its ‘rose-tinted case studies’. We need better reporting of involvement, but also more clarity on what ‘impact’ means.
I think most of the stuff about impact that I see is kind of case studies talking about, "Oh we did this," and personally I think they're often very kind of rose-tinted case studies and they're kind of like, "Well it was great because we did PPI, isn’t that nice of us?" kind of thing. And I think, I think we do need to, you know, assess its impact, assess what happened with PPI, how did it impact the research if it did? I think there should be some way for the PPI members involved to say what they think the impact was, and I think it's tough because I think actually then we’d just start getting examples of where it didn’t have an impact or where it had a negative impact either on the researchers or on the people involved. Personally I don’t think that would be a reason not then to do it. What sold me I think, as I said before, is this thing that I think we should do it. For me it's, I think it's about transparency and accountability in some ways and for me the impact is kind of an unanswered question. Yeah I think it's, I think a lot more needs to be done, I think sort of methodologically and in terms of encouraging or enforcing proper reporting about it, and I think until that happens I'm not sure what we'll start to see. But I know someone I'd spoken to the other day who used the term, you know, "Oh well if we start really evaluating this it'll be de-bunked within a few years." The idea that we’ll show that it's not, it's not making better research. But as I say that kind of leads onto this question of it depends what you mean by better yeah, so it's complicated.
We need better evidence, but researchers don’t feel able to voice any negative views or bad experiences of involvement. We need better evidence, but researchers don’t feel able to voice any negative views or bad experiences of involvement.
We need better evidence, but researchers don’t feel able to voice any negative views or bad experiences of involvement. We need better evidence, but researchers don’t feel able to voice any negative views or bad experiences of involvement.
And I suppose I'd say to them that I think the reason for us doing work in PPI recognise that is has pros and cons and that it is very complicated and that is something that we want to start to capture and we want to start to evaluate and think about and so I wouldn’t use those experiences as kind of, 'Oh I'm done with PPI because I don’t buy into this; isn’t it all lovely framework?' I'd say, "No you should stick with it but think about well how can that get evaluated and captured; how does this feed into lessons about the kind of support that actually we need to deliver genuine PPI?" Because I think it's kind of stuck at the moment from people who just think it's rubbish and people who outwardly at least think it's the best thing since sliced bread and actually I think the reality is in the middle; I think actually that’s where most PPI research is, is somewhere in the middle and I think that’s where the progress is going to be made actually. Kind of the how you capture that complexity and start pulling it apart and I think there's potential there to do really interesting stuff yeah [laughs].
Sarah A trains other researchers in PPI but never had formal training herself. Training needs to be about managing relationships as well as basic practical advice.
Sarah A trains other researchers in PPI but never had formal training herself. Training needs to be about managing relationships as well as basic practical advice.
PPI is about building partnerships over time, and supporting and training people to get involved. Wanting everyone to be completely ‘naïve’ is unrealistic and devaluing.
PPI is about building partnerships over time, and supporting and training people to get involved. Wanting everyone to be completely ‘naïve’ is unrealistic and devaluing.
I do. But this again, I know this is an issue, this is a potential contentious issue. My, so the kind of debates I've had are people who have this view, for example, that you should have naïve PPI so that the person who is coming is a naïve member of the public who doesn’t have, kind of, that research hat on or those research blinkers or whatever you're kind of assuming research does to people, and who is just giving a, I guess a pure untainted view of what it's like to be the member of the public who suddenly gets the letter about the research trial or who suddenly hears about this research finding and they can give that, just that – that sort of untainted view of just what it's like to experience that. And I understand that and I think that’s valuable. But because I would, I think PPI should be more about a continued involvement and partnership; I think that does need then, training and support. I don’t think you can ask someone to walk off the street and, as I said, comment on an analysis plan and comment on an ethics application.
So in that case I think we do have an obligation to offer support to them and to teach them, or to offer them opportunities to train if they want them. As I said, it goes back again of course; you know, people would be different I think; people, some people come on and they want to just give their opinion and other people, I think, really want to get more involved. And I personally think that there is a lot of, a lot to gain from having, you know, what get called the ‘expert PPI members’. I don’t like this idea that once you become more expert in PPI suddenly you lose that interest or that passion. So my PPI partner, my collaborator I talked about, her issues, her passion is about carers and things affecting carers, and she's incredibly experienced and knowledgeable about PPI, far more than I am.
For example, she has huge amounts of experience in doing it and the idea that that taints her, her passion or the sort of, the raw experience of saying, "But this is what it feels like to be that person." I don’t think that’s true at all and I think, I personally think, that kind of devalues the contribution that those people can make who are these amazing people who have this passion, who want to share their experiential knowledge with us, but who also have experience and skills that mean they can do that. I think they're amazing, you know, and it frustrates me sometimes when I see this argument, "well, we'd better not train them because then they’ll, you know, they’ll be too much like us," or something. I don’t know, I find that, I find that strange. But as I said, that’s, I know it's an issue of debate and I'm probably being unfair to people who have the alternate view but it's my interview so I can [laughs].
Sometimes researchers have felt forced into doing PPI, with little belief in its value for their projects and little support to do it well.
Sometimes researchers have felt forced into doing PPI, with little belief in its value for their projects and little support to do it well.
I think there were people going, "But you can't do PPI on my quantitative survey," or, "You can't do PPI on a systematic review, well it's physically impossible," and now I think you know they’ve realised actually that'll get their funding application balanced, that will get them a red, you know, cross from the funder and that kind of thing. But in some ways maybe that’s had a negative implication you know, people think well, 'Well I was forced to do it; I never bought into it really, but it's something that you have to do.' I think… I think there's, I think there's scepticism ; you know I think as researchers you know your job is to critique stuff and say, "Well where's the evidence base?" and so when you say something like, "PPI makes better research," they say, "Well where's the evidence base?" So I don’t think the evidence base is there yet.
So I think it's natural in some ways and I do think there's a kind of a cultural issue. I think it's, I think if, you know, you’ve learned to do research and that involves treating and relating to patients and participants in a specific way and how you communicate with them and what you sort of take from that encounter and what you do with it and your perceptions of what our role is which, you know, to some people it's perhaps, it comes back to this idea, "Well what if you know a lot of patients don’t know what's best for them," and that’s where, you know, research can be very important because it takes data or it takes opinions and it can give up all of you and I think for them they look at it and it, they are not convinced by the idea that getting, you know, some nice lady to come along and say and critique your study; I think they think well what is that going to do . Yeah, and as I say, I think that cultural difference in, so how you then relate to people and that’s really, I think that’s really hard.
You know I think PPI requires a lot of personal skills and I would say, I don’t know if I have all the personal skills [laughs] that I think are required. And that’s kind of the problem, you just get, you can end up just thrown into it; you're expected to, you know, perhaps talk to people who are very upset about certain treatment or something. And then you’ve got to tell them about your research, and you’ve got to communicate it in a way that is accessible and even handed. And then you’ve got to be able to draw out people's opinions, and then you’ve got to be able to negotiate with them. And then you’ve got to be able to, you know, it's a lot of, it's asking a lot, I think, of researchers as well. So I think there's scepticism and I think there's sort of a reluctance to kind of, you know, get engaged with something which can be very, very difficult sometimes.
In Sarah A’s view, having sustained organisational investment over time would make the biggest difference to effective involvement.
In Sarah A’s view, having sustained organisational investment over time would make the biggest difference to effective involvement.
What if they want to go on a training course, you know where does the money for that come from? So I think in my experience PPI is almost always underfunded and yet it will still sometimes be the bit on a grant that hasn’t had the money spent on it, but that’s usually because people have somehow forgotten to do the PPI which happens surprisingly often. And I mean, so to give an example now is – so that the project that’s started this all with my PPI collaborator that we do the project on carers and now we really want to take that forward and get a bigger amount of funding for it. And I'm lucky in that at the moment, I'm fully funded on a Fellowship and I have a degree of freedom to sort of put effort into work to build future projects. But apart from that there isn’t anything there to kind of sustain that and so you could potentially have what I think is a great project that was PPI you know instigated and led and now kind of where is the support to go forward with that? And that’s, you know, that’s talking about specific research if you think about this issue of training, you know where's the funding to deliver training.
So the training that I deliver in the Centre we just do that, you know, there isn’t any kind of external money to support that. So no, I think that, for me, is the biggest gap between the fact that every, pretty much every funding body, now has a statement somewhere about how important patient involvement is and how seriously they take it and that does not translate financially, I think, at all really. And I think the more, I think people who, the PPI partners themselves who have been in PPI for a lot longer, I think they start to see that and I think that sends a dreadful message about how this is just nice words rather than something that is backed up with genuine resources. It's, you know, money talks at the end of the day I think not adequately resourcing it I think sends a message that we don’t really believe in it and we don’t really want to give it the best chance that it could have really.
Too often involvement is left to junior staff. Sarah A would like to see more senior investigators actually attending PPI meetings and demonstrating visible commitment.
Too often involvement is left to junior staff. Sarah A would like to see more senior investigators actually attending PPI meetings and demonstrating visible commitment.
You said there that you said you're a nice young girl [R laughs over I]. Is there a gender issue about who gets to be the PPI co-ordinator or who does PPI?
[Laughs] I wouldn’t say I've observed that formally. But in my experience that’s how it tends to get done, you know. I think - yeah you're essentially kind of, which is insulting really both to I think, to the nice young girl and to the patients where it's almost like the kind of the PIs saying essentially it's some kind of coffee morning. Like kind of, "Oh well, you know, you're nice and you can go and chat to them about their kids or something can't you?" So I wouldn’t say formally that there’s a gender issue, I think it's perhaps more of this, it shows a, I think it's perhaps, in some ways, hints at the lack of value that is being put on it that it's essentially almost just an exercise in being nice to members of the public for an hour or rather than, "Do you have the skills to sort of properly engage with this?" and also an issue that I often sort of think about is this, you know, if you're telling this group of people that they're going to impact the study or that their voices are going to be heard and yet it's the most junior member of the team who's hearing and she can't go back, or he, can't go back to their PI [principal investigator] and say, "Well you know now we're going to do this because the PPI group said. So…"
I personally would always like to see people who have a bit more responsibility and authority for studies actually going to these meetings because I think that would demonstrate to the group that it's. I mean, I've been at a PPI meeting and you see the people I could overhear the PPI members going, "They're all very young aren’t they, they're very young." And you do kind of feel like ‘well are they going to trust that I'm taking this back’. So I think there's an issue of making sure that people with, you know, people with authority to take decisions about the project, are the people who actually go and consult and collaborate with the PPI members rather than it just being, you know, left to the most junior member of the team.
Involvement can be burdensome and wasteful both for participants and researchers. Dealing with hostile or ‘single issue patients’ and lack of senior support can make it hard.
Involvement can be burdensome and wasteful both for participants and researchers. Dealing with hostile or ‘single issue patients’ and lack of senior support can make it hard.
I know finance is always a big issue; a very sensitive issue about not getting adequate, sort of, compensation, I guess, for the time they spend on things, or the speed with which they get that recognition. There are ownership issues, you know, if they come and they say, "Well this was my idea and then you took it, and made it something that wasn’t my idea but you're saying it was PPI inspired," you know. So I think they're kind of the issues for the PPI members. So there's kind of the burden, the cost, and the level of, I think, how much they feel a genuine collaboration is going on. I think, you know, that thing, that issue of saying, "Oh well you're doing this to tick the box," that comes up a lot, and I think they're rightly, they rightly get very angry about that.
From a researcher’s point of view I think there's a fear that kind of you'll sit there with these PPI partners and they’ll just tell you what you do is rubbish - which no-one wants to hear [laughs]. I know a lot of people talk about this issue of, the single issue patient. That you're going to have just one person who comes on with an axe to grind and that gets set alight, you know, they're just going to, they're not going to be able to think, sort of, more broadly, or be able to compromise about where research should go. There's burden for the researchers as well. In my experience it's typically, sort of, the more junior researchers who basically get told, "Oh you can do the PPI bit on this project," or told, you know, "Here's the two hundred quid we budgeted for it, go and run a focus group or something." And they, you can get very little support to do that, so, and I think that can be, you know, that’s basically adding to the work you’ve got to do and makes it more intimidating that you're kind of floundering to try and run what actually I think can be very complicated sort of projects, complicated work. It involves a lot of diplomacy and a lot of patience and, you know, if you’ve just been thrown into it by your PI who then says, you know, "Can you write the paragraph on this for the trial report?" those two things don’t match up at all.
And I think a lot of them do have this question that ‘well is it making things better?’ You know, ‘how is this improving my research?’ How is this, you know – I think they worry that it's a, it is a tick box thing and it's kind of a, that basically, you have to do this now because the NHS and the NIHR tell us we have to do it. So we tick the box and actually it's a waste of money, it's a waste of time, and it's not genuinely going to improve things so I think, I think there's. I think people who want to engage with it, I think it's this issue of burden and anxiety over whether they’ve got the skills to do that, and the support to do that. And then I think on the other side there's people who are quite cynical about it or sort of very sceptical about it, and for them I think it's more, they don’t buy into the idea that they should or need to be doing it. So that’s what I think.
Sarah agrees paying people is an important principle, but wants firmer national guidance on what to pay and how to cost this in grant proposals. Slow payment processes can feel disrespectful.
Sarah agrees paying people is an important principle, but wants firmer national guidance on what to pay and how to cost this in grant proposals. Slow payment processes can feel disrespectful.
I think there's a lack of guidance on what number, you know, what figure you put on it. Probably the question I get asked most often by people in the department is, you know, “what do I pay them?” You know, is it fifty pounds, is it twenty pounds and there seems to be a reluctance, an understandable reluctance I guess, to put a number on that but it does, I think, then leave it essentially at the mercy of what happens locally and at the mercy of, people always go for, you know, the smallest number that they can and if they find out that someone in, you know, the next university only pays ten pounds an hour, then they’ll go with ten pounds an hour. I think it's a really complicated one and I know it's, I think. I think for the PPI members I think, I think that they feel it's disrespectful when they're not given what they would view as appropriate sort of compensation. And an issue we have here is just the speed with which they get, you know, the refunds.
There's a thing in universities you wait, you know, six months to get your expenses processed or something and I think for, you know, the PPI partners who are saying, "Well I'm waiting six months later, I still haven’t been paid for this." It feels disrespectful I think. But then, you know, that becomes a struggle for us because we don’t have any sway over finance [laughs] to say, "Please pay these people quicker." So I don’t know, I think the finance one is a really, really complicated one.
And I do think it's one where, I think there is a need for kind of leadership from above whether that’s, you know, the NIHR saying, "These are the figures that we recommend; this is the policy we recommend about finance," or, as we're trying to do here, we're trying to get kind of a top-down, like a faculty wide kind of strategy that says, “This is the amount that, kind of, we recommend that people get, this is how we recommend you pay people.” So recommending kind of cash on the day rather than expenses if you can and things like that. But yeah it's a pain in the arse, it really is [laughs] – for us and for them, I think it's a real pain so.
From her experience Sarah does not believe anyone would seriously be motivated to get involved just because of money.
From her experience Sarah does not believe anyone would seriously be motivated to get involved just because of money.
Both patients and members of the public can contribute, depending on the topic. Sarah A is annoyed when people dismiss PPI as ‘just one person’s opinion’, though diversity is important.
Both patients and members of the public can contribute, depending on the topic. Sarah A is annoyed when people dismiss PPI as ‘just one person’s opinion’, though diversity is important.
But as, I think the idea of having ‘just’ a member of the public, I think that is really useful because in the broader sense of, as I said, being able to explain what we're spending the public's money on and have members of the public agree with that, then yes they should be. They don’t have to of had specific sort of experiences and illness, and I think that is important to get a sense of, sort of, the diversity of experience patients can have. You know, there's the classic thing they often, you know, there's perhaps just one PPI member who gets involved and it always really frustrates me when people will, you know, they’ll only budget to have one PPI member on a project and then they’ll say, "But the problem is it's just one person's opinion," and you think, 'Well there was a simple way round that wasn’t there at the start?' - Sort of numerically speaking.
So I think, you know, yeah I do think there's a role for members of the public and I suppose I could think of a lady who attends our group who hasn’t had a specific condition as such, or a treatment, I don’t think she'd define herself as a patient. But she'd just define herself as well, you know, I am, if you're a member of the public in the UK you use the NHS; you are a patient in some sense and so you can still bring, you know, experience and insights into that. So, yeah.
And the other thing you touched on there was the issue of representativeness.
Mm
What do you think about that in a debate?
I do think that’s an important debate. I think, you know, there's the beyond usual suspects…
Hm mm
…kind of argument and I think that is important. I think you go to PPI group meetings and it is predominantly kind of white, middle class, retired. So I think there is an issue of how we reach out to the easily ignored sections of the population and service users who might not typically get involved in this kind of work. I suppose having said that, part of me always worries again that it's another way of devaluing the contribution that those people make. I think if you're saying, for example, that I want to talk to a group about their experience of depression, then I think if you get people who talk to you about the experience and you go, "Oh but I'm not going to listen to it because you're not actually my target group."
In a way that’s your fault, you know, you should have gone out there and tried to recruit to that target. But I also did think you shouldn’t devalue the experiences of anyone if it's, you know, if its experiential knowledge as we say, then their experience is as legitimate whoever they are. So that’s my worry, that’s I think, I get, I worry about that argument, as I say, because I think it can be used to, to devalue what people are saying. But I think, you know, everyone who works in PPI needs to kind of acknowledge that we do have a problem with lack of representation and to think about how it is that we get people involved in PPI because there's obviously a lot of people we're missing, or we're not reaching, or we're putting them off somehow. And I think we should be asking ourselves those questions, definitely. But I suppose what I'd say is that, you know, the white, middle class, retired PPI partners that I work with all say that as well. You know, so they acknowledge that this is a problem and they really want to do something about it as well, so.
Sarah A reflects on two possible futures for PPI. It may become a normal part of practice, or it may fall by the wayside if people think it doesn’t work.
Sarah A reflects on two possible futures for PPI. It may become a normal part of practice, or it may fall by the wayside if people think it doesn’t work.
And that partly I think is why we do need to start measuring things and sharing outputs and stuff and just start making sure it gets seen before it just kind of crumbles away and becomes something you don’t bother doing anymore.
…I suppose what I'm hoping will happen I think if, I think if it can be methodologically developed more in terms of what you measure, how you measure, how you report it, how it contributes to the sort of wider issues in terms of getting stuff implemented and doing work that is of importance and things. Then I think perhaps people will start taking it more seriously as a research activity almost, or as an activity that feeds research and that is important to the research world and to us as researchers and I hope then it would be sustained because it would have sort of legitimacy and maybe then there could be people who, you know, the way you specialise in qualitative research and mental health and PPI and it becomes something that is, you know, part of your repertoire but acknowledging that it is a complicated issue, it's not just something you give to the youngest member of the team, you, there are specialists in it . Yeah I suppose that, that probably sounds really selfish because it really sounds like I'm saying, "I'd quite like it if I can go into a role as PPI specialist."
But even I think yeah, I think if it got more, if it had that legitimacy of being seen as a serious research endeavour then I think people would throw more money at it; I think PIs would care more about it and I think hopefully that would cycle that by taking it more seriously it's able to show more serious outcomes and it's able to demonstrate influence or value in some way, whether that’s an intrinsic value or in terms of measureable outputs and I would hope then that it would become - At the moment I think it's a self-defeating cycle that people don’t do it properly, they don’t report it and then when you ask people about it they go, "Well it's rubbish isn’t it?" and it's kind of, “Well of course it was rubbish, you set it up to fail essentially” and so it's this thing of giving it a fair crack of the whip I think to do it properly and in a sound way and a transparent way to let it happen and see if it can make an contribution and then, you know, then if it is absolute rubbish then you know. And that’s one take on it but at the moment I think the future of it I hope would just be that people start taking it seriously and so we start looking at it, genuinely looking at it as part of research and what it contributes yeah [laughs]. It's a tough question.
Sarah A feels very responsible for the people who get involved and feels guilty if progress with the research isn’t as good as they hoped. It’s an ‘emotional burden’.
Sarah A feels very responsible for the people who get involved and feels guilty if progress with the research isn’t as good as they hoped. It’s an ‘emotional burden’.
Yeah I think so. I think, I was saying just how I like the fact that my PPI partner is on at me to take this forward and to move forward and to do stuff with it. When I'm feeling like my 'To do list' is endless I don’t like that voice you know and it then feels, but it feels different to not be progressing as well with that as to not progress well with other projects – you know there's other projects that I, you know, need time throwing at them but it's kind of almost a strategic thing and it's, "Oh that needs that and that needs that," whereas this feels like, it feels a bit more personal because there is a person attached to it and, you know, I feel quite guilty sometimes if I'm not spending time on it, or feel guilty like, oh have I, you know have I not done the right expectation management, that you know, does she think this definitely is going to get funded when it isn’t and a lot of the time I think that’s inaccurate, I think actually she's very pragmatic about things and but it is a bigger pressure I think, and that I don’t think gets acknowledged at all.
And that again I'd almost feel a bit daft kind of, you know, if you're sitting there talking about, “OK, so I need to do this for my CV and this for my CV”, and you go, “Well, PPI will look good on my CV”, but also I just feel really bad about it you know, that sounds a bit silly or I don’t think that’s going to sell it to, you know, my supervisors. But that’s why ideally I think I would like for it to be acknowledged that, you know, maybe it's a good thing that I'm trying to continue this relationship with this person; maybe it's a good thing that I'm trying to sustain that involvement and that collaboration and not just say, "Well you know my time on this is done so I'm going to leave you now." And I think you feel, I think I now feel a responsibility as well to people who I've done PPI with that then if they go and do PPI with another group I worry that group isn’t going to you know treat them right almost which sounds really silly but you sort of feel this responsibility but, you know, they're not going to collaborate them in this way or they're not going to make sure they pay their finances on time and stuff like this and so you end up then feeling responsible for them in a way that I wouldn’t feel responsible for a colleague on another project going to another team.
Like I say I don’t think that’s intrinsically a bad thing. I think there are elements of that that are good. You know ideally I like having that more personal relationship but yes it does have a certain sort of emotional burden to it I guess which I don’t think gets acknowledged or I don’t think they really get time to sort of explore that. But, you know.
Sarah A suggests people who get involved should remember most researchers really do care about patients. But if they come across tokenism they should challenge it.
Sarah A suggests people who get involved should remember most researchers really do care about patients. But if they come across tokenism they should challenge it.
You know don’t sort of collude with these researchers who are doing a tokenistic job by engaging with it tokenistically and they probably sound at crossed purposes on the one hand saying be nicer to researchers and on the other hand well saying give them hell. But actually I think, I think somewhere in the middle of that I think there is a balance of saying, "I'm here as a partner so that means I appreciate your expertise as a researcher, but also I'm not here to be taken for granted," I think that, I think would be, that’s a good way to approach it I think and I hope, and hope they feel comfortable doing it [laughs] you know.